|
FY2025
12 months to Dec 31, 2025
|
|
|---|---|
| Net sales | |
| Cost of sales | |
| Gross profit | |
| Operating expenses: | |
| Research and development | |
| Selling, general, and administrative | |
| Total operating expenses | |
| Loss from operations | |
| Other income, net | |
| Loss before provision for income taxes | |
| Provision for income taxes | |
| Net loss | |
| Deemed dividends | |
| Net loss attributable to common stockholders | |
| Net loss per share attributable to common stockholders, basic | |
| Net loss per share attributable to common stockholders, diluted | |
| Weighted-average shares used in computing net loss per share attributable to common stockholders, basic | |
| Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted | |
| Comprehensive loss: | |
| Currency translation adjustment | |
| Comprehensive loss | |
| Deemed dividends | |
| Comprehensive loss attributable to common stockholders |
Loading...
